Computational Biology Market

Computational Biology Market, By Type (Cellular and Biological Simulation (Computational Genomics, Computational Proteomics, Pharmacogenomics, and Others (Transcriptomics/Metabolomic)), Disease Modeling and Simulation Applications (Drug Discovery, Drug Development)), By Tools (Content/Database, Analysis Software and Services, and IT Infrastructure (Hardware)),and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.

Market Dynamics

The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received US$ 55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay’s genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.

Key features of the study:This report provides an in-depth analysis of the global computational biology market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base yearIt elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this marketThis study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key playersIt profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategiesThe key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tacticsThe global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analystsStakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology marketDetailed Segmentation:Global Computational Biology Market, By Type:Cellular and Biological SimulationComputational GenomicsComputational ProteomicsPharmacogenomicsOthers (Transcriptomics/Metabolomic)Disease Modeling and Simulation ApplicationsDrug DiscoveryDrug DevelopmentGlobal Computational Biology Market, By Tools:Content/DatabaseAnalysis Software and ServicesIT Infrastructure (Hardware)Global Computational Biology Market, By Region:North AmericaU.S.CanadaLatin AmericaBrazilMexicoArgentinaRest of Latin AmericaEuropeU.K.GermanyFranceSpainItalyRussiaRest of EuropeAsia PacificChinaJapanIndiaAustraliaSouth KoreaASEANRest of Asia PacificMiddle EastGCC CountriesIsraelRest of Middle EastAfricaNorth AfricaCentral AfricaSouth AfricaCompany ProfilesAccelrysCertara, L.P.Chemical Computing Group Inc.Compugen, ltd.Entelos, Inc. (Rosa & Co. LLC)Genedata AGInsilico Biotechnology AGLeadscope, Inc.Nimbus Discovery LLCRhenovia Pharma SASSchrodingerSimulation Plus, Inc.